The BrainACT study: acceptance and commitment therapy for depressive and anxiety symptoms following acquired brain injury: study protocol for a randomized controlled trial.

ABSTRACT: BACKGROUND:Following an acquired brain injury, individuals frequently experience anxiety and/or depressive symptoms. However, current treatments for these symptoms are not very effective. A promising treatment is acceptance and commitment therapy (ACT), which is a third-wave behavioural therapy. The primary goal of this therapy is not to reduce symptoms, but to improve psychological flexibility and general well-being, which may be accompanied by a reduction in symptom severity. The aim of this study is to investigate the effectiveness of an adapted ACT intervention (BrainACT) in people with acquired brain injury who experience anxiety and/or depressive symptoms. METHODS:The study is a multicenter, randomized, controlled, two-arm parallel trial. In total, 94 patients who survive a stroke or

SUBMITTER: Rauwenhoff J 

PROVIDER: S-EPMC6935100 | biostudies-literature | 2019 Dec

REPOSITORIES: biostudies-literature